KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket Capitalization

AbCellera Biologics (ABCL) Asset Utilization Ratio: 2021-2023

Historic Asset Utilization Ratio for AbCellera Biologics (ABCL) over the last 3 years, with Dec 2023 value amounting to 0.03.

  • AbCellera Biologics' Asset Utilization Ratio fell 91.92% to 0.03 in Q4 2023 from the same period last year, while for Dec 2023 it was 0.03, marking a year-over-year decrease of 91.92%. This contributed to the annual value of 0.02 for FY2024, which is 19.37% down from last year.
  • As of Q4 2023, AbCellera Biologics' Asset Utilization Ratio stood at 0.03, which was down 23.31% from 0.03 recorded in Q3 2023.
  • Over the past 5 years, AbCellera Biologics' Asset Utilization Ratio peaked at 0.40 during Q1 2021, and registered a low of 0.03 during Q4 2023.
  • Its 3-year average for Asset Utilization Ratio is 0.26, with a median of 0.32 in 2022.
  • Per our database at Business Quant, AbCellera Biologics' Asset Utilization Ratio increased by 4.19% in 2022 and then tumbled by 91.92% in 2023.
  • Over the past 3 years, AbCellera Biologics' Asset Utilization Ratio (Quarterly) stood at 0.30 in 2021, then climbed by 4.19% to 0.31 in 2022, then plummeted by 91.92% to 0.03 in 2023.
  • Its last three reported values are 0.03 in Q4 2023, 0.03 for Q3 2023, and 0.10 during Q2 2023.